Oppenheimer Asset Management Inc. Johnson & Johnson Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 575,944 shares of JNJ stock, worth $89.3 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

575,944

Previous 573,904 0.36%

Holding current value

$89.3 Million

Previous $83.9 Million 11.27%

% of portfolio

1.16%

Previous 1.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$145.48 - $167.38 $296,779 - $341,455	2,040 Added 0.36%	575,944 $93.3 Million
Q2 2024 Aug 08, 2024	BUY	$144.38 - $157.78 $12 Million - $13.1 Million	82,787 Added 16.86%	573,904 $83.9 Million
Q1 2024 May 06, 2024	BUY	$155.22 - $162.74 $1.01 Million - $1.05 Million	6,481 Added 1.34%	491,117 $77.7 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $3.01 Million - $3.28 Million	-20,644 Reduced 4.09%	484,636 $76 Million
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $1.9 Million - $2.12 Million	-12,177 Reduced 2.35%	505,280 $78.7 Million
Q2 2023 Aug 02, 2023	SELL	$154.35 - $166.11 $2.65 Million - $2.86 Million	-17,191 Reduced 3.22%	517,457 $85.6 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $2.77 Million - $3.31 Million	18,358 Added 3.56%	534,648 $82.9 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $1.14 Million - $1.28 Million	-7,143 Reduced 1.36%	516,290 $91.2 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $5.63 Million - $6.26 Million	34,893 Added 7.14%	523,433 $85.5 Million
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $464,540 - $513,759	2,762 Added 0.57%	488,540 $86.7 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $6.12 Million - $6.95 Million	38,708 Added 8.66%	485,778 $86.1 Million
Q4 2021 Feb 02, 2022	BUY	$155.93 - $173.01 $73,754 - $81,833	473 Added 0.11%	447,070 $76.5 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $1.3 Million - $1.45 Million	8,056 Added 1.84%	446,597 $72.1 Million
Q2 2021 Aug 03, 2021	BUY	$159.48 - $171.07 $1.39 Million - $1.5 Million	8,743 Added 2.03%	438,541 $72.2 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $942,758 - $1.05 Million	6,159 Added 1.45%	429,798 $70.6 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $2.2 Million - $2.53 Million	-16,044 Reduced 3.65%	423,639 $66.7 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $1.76 Million - $1.92 Million	-12,508 Reduced 2.77%	439,683 $65.5 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $1.84 Million - $2.22 Million	-14,282 Reduced 3.06%	452,191 $63.6 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $223,947 - $310,289	2,015 Added 0.43%	466,473 $61.2 Million
Q4 2019 Feb 07, 2020	BUY	$127.5 - $146.44 $254,490 - $292,294	1,996 Added 0.43%	464,458 $67.8 Million
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $1.22 Million - $1.37 Million	-9,632 Reduced 2.04%	462,462 $59.8 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $1.22 Million - $1.34 Million	-9,267 Reduced 1.93%	472,094 $65.8 Million
Q1 2019 Apr 24, 2019	SELL	$125.72 - $139.79 $1.15 Million - $1.28 Million	-9,144 Reduced 1.86%	481,361 $67.3 Million
Q4 2018 Jan 30, 2019	SELL	$122.84 - $147.84 $617,025 - $742,600	-5,023 Reduced 1.01%	490,505 $63.3 Million
Q3 2018 Oct 26, 2018	SELL	$121.58 - $142.88 $753,796 - $885,856	-6,200 Reduced 1.24%	495,528 $68.5 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $1.65 Million - $1.82 Million	-13,813 Reduced 2.68%	501,728 $60.9 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $1.19 Million - $1.41 Million	-9,543 Reduced 1.82%	515,541 $66.1 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $68 Million - $71.1 Million	525,084	525,084 $68.3 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Johnson & Johnson Transaction History